Clinikally vs Noom
Side-by-side comparison of AI visibility scores, market position, and capabilities
Gurugram India YC S22 dermatology telemedicine at $9.9M revenue 2024 with 1.5M customers; $3.1M total ($2.6M Tribe/Goodwater/Sequoia seed Sep 2023) competing with Practo for India digital dermatology care.
About
Clinikally is a Gurugram, India-based dermatology telemedicine and online pharmacy platform — backed by Y Combinator (S22) with $3.1 million in total funding including a $2.6 million seed in September 2023 led by Tribe Capital with Goodwater Capital, Sequoia Capital, and Rebel Fund — providing 1.5 million customers with integrated dermatological consultations, AI-assisted skin analysis, and prescription delivery for skin and hair conditions through a digital-first model that democratizes access to dermatology care across India. Founded in 2022 by Arjun Soin, Clinikally achieved $9.9 million in revenue in 2024 with a 76-person team, addressing the significant dermatology care access gap in a country where there are fewer than 10,000 dermatologists for 1.4 billion people.
Noom is a digital weight health program combining psychology-based behavioral coaching, food logging, and human coaching to help members build sustainable healthy habits.
About
Noom is a digital health company founded in 2008 that has grown into one of the most widely used weight management platforms, serving millions of members through its psychology-driven approach to behavior change. The platform combines daily lessons on cognitive behavioral techniques, food logging with a traffic-light color-coding system, personal coaching from trained health coaches, and group support to help members change their relationship with food and exercise. Noom raised over $540M and reached a $3.7B valuation, establishing it as a leading consumer digital health company. The company has expanded beyond weight loss into a broader weight health platform addressing both weight management and weight-related conditions including type 2 diabetes management with its Noom Med offering that includes GLP-1 medication prescribing. As GLP-1 medications like Ozempic and Wegovy have transformed the weight loss market, Noom has positioned its behavioral coaching as essential to sustainable results alongside medication. The platform serves both direct-to-consumer subscribers and employer health plans that offer Noom as a weight management benefit for their workforces.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.